Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Dexamethasone/Mitotane

Adrenal crisis following drug-drug interaction and hyperlipidaemia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Cortez S, et al. Mitotane in the Treatment of Adrenocortical Carcinoma: Metabolic and Endocrine Disruption. Journal of the Endocrine Society 5 (Suppl.): A702, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.1430 [Abstract] Cortez S, et al. Mitotane in the Treatment of Adrenocortical Carcinoma: Metabolic and Endocrine Disruption. Journal of the Endocrine Society 5 (Suppl.): A702, May 2021. Available from: URL: https://​dx.​doi.​org/​10.​1210/​jendso/​bvab048.​1430 [Abstract]
Metadaten
Titel
Dexamethasone/Mitotane
Adrenal crisis following drug-drug interaction and hyperlipidaemia
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56808-5

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Cefepime

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Amantadine